Surface Oncology, Inc. SURF
Set alert
1.07 0.00 0.00%
At close · Sep 7
1.01 Day range 1.09
52-week range unavailable
- Open
- 1.06
- Prev close
- 1.07
- Mkt cap
- 65.08M
- Vol
- 1.46M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.01
- High
- 1.09
- Forward P/E
- -0.79
- Beta
- 1.74
- Short ratio
- 0.33
- Inst. own
- 50.11%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 1, 2023
- 50-d avg
- 0.77176
- 200-d avg
- 0.84846
- 1y target
- 2.38
6M chart
Events in this range
- May 4, 2023Earnings: —; estimate -0.37; surprise —%
- May 5, 2023Rating: HC Wainwright & Co. · — → Buy
- Jun 20, 2023Downgrade: HC Wainwright & Co. · Buy → Neutral
- Jun 20, 2023Downgrade: Baird · Outperform → Neutral
- Jun 20, 2023Downgrade: Wedbush · Outperform → Neutral
- Jun 23, 2023Rating: Baird · Outperform → Outperform
- Aug 2, 2023Earnings: —; estimate -0.34; surprise —%
Signals (14)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Aug 25, 2023 | 3 years ago |
| SMA: Bullish | Aug 21, 2023 | 3 years ago |
| SMA: Bearish | Aug 17, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 14, 2023 | 3 years ago |
| RSI: Overbought | Jul 6, 2023 | 3 years ago |
| MACD: Buy Signal | Jun 21, 2023 | 3 years ago |
| MACD: Sell Signal | Jun 8, 2023 | 3 years ago |
| SMA: Bullish | May 26, 2023 | 3 years ago |
| SMA: Bearish | May 25, 2023 | 3 years ago |
| SMA: Bullish | May 22, 2023 | 3 years ago |
| RSI: Overbought | May 22, 2023 | 3 years ago |
| SMA: Bullish | May 18, 2023 | 3 years ago |
| MACD: Buy Signal | May 8, 2023 | 3 years ago |
| MACD: Sell Signal | Apr 26, 2023 | 3 years ago |
Analyst view
Consensus: hold
Hold
Price target (mean) 2.38 +122.4% upside
Now 1.07
- Target (low)
- 1.00
- Target (mean)
- 2.38
- Target (high)
- 5.00
Ratings (0m) 2 1 buy · 1 hold · 0 sell
- Strong buy0
- Buy1
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 5
- 2 months ago 6
- 3 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.34 | -0.35 – -0.33 | -0.46 | +26.1% | 0 | 0.0% | 5 |
| Next quarter | -0.35 | -0.37 – -0.34 | -0.39 | +10.3% | 0 | 0.0% | 5 |
| Current year | -1.29 | -1.42 – -1.11 | -1.14 | -13.2% | 3.75M | -87.5% | 5 |
| Next year | -1.18 | -1.54 – -0.95 | -1.29 | +8.5% | 0 | 0.0% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 23, 2023 | Baird | Maintained | Outperform | Outperform |
| Jun 20, 2023 | Wedbush | Downgrade | Outperform | Neutral |
| Jun 20, 2023 | Baird | Downgrade | Outperform | Neutral |
| Jun 20, 2023 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| May 5, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 10, 2023 | Wedbush | Reiterated | — | Outperform |
| Mar 10, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Nov 3, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 8, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| May 18, 2021 | BTIG | Initiated | — | Buy |
| Sep 4, 2020 | HC Wainwright & Co. | Initiated | — | Buy |
| Aug 28, 2020 | Wedbush | Initiated | — | Outperform |
| Sep 19, 2018 | Baird | Initiated | — | Outperform |
| May 14, 2018 | Goldman Sachs | Initiated | — | Neutral |
| May 14, 2018 | Cowen & Co. | Initiated | — | Outperform |
| May 14, 2018 | Evercore ISI Group | Initiated | — | Outperform |